Acute neurovascular syndromes: hurry up, please, it's time.
Kennedy
J
J
Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.
Buchan
A M
AM
D000208:Acute Disease; D015415:Biomarkers / Q000032:analysis; D002545:Brain Ischemia / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D038524:Diffusion Magnetic Resonance Imaging; D018450:Disease Progression; D004632:Emergency Medical Services / Q000458:organization & administration / Q000639:trends; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D011237:Predictive Value of Tests; D018570:Risk Assessment; D013577:Syndrome; D015912:Thrombolytic Therapy / Q000009:adverse effects; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D015415:Biomarkers; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator